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ABSTRACT 
Copper vapour laser with yellow beam wavelength at 578 n m was 
applied in the treatment of vascular lesions, such as the port-wine stains 
of the skin and the cavernous haemangiomas in the oral cavity. 
Satisfactory results proved its efficacy. Where as the application of the 
copper vapour laser for the treatment of the vascular anomalies in the 
gastrointestinal tract remains uncertain. Experiments using Sprague 
Dawley rats as animal model, was set up to test the safety and, if 
possible, the treatment dose for the copper vapour laser in the 
gastrointestinal tract. The results obtained show potential dangers in 
perforation of blood vessels and unpredictable perforation of the rat 
stomach. And thus the author caution the use of the copper vapour laser 
in the gastrointestinal tract for the treatment of vascular lesions like 
esophageal varices. 
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CHAPTER 1 : INTRODUCTION 
Copper vapour laser with yellow light wavelength at 578 n m has 
been used to treat superficial vascular lesions, such as port-wine stains, 
telangiectasia, spider naevi and also cavernous haemangiomas in the 
oral cavity. It gives satisfactory improvement in most patients ( Tong et 
al.，1993; Walker et al” 1989; Pickering et al•，1990; Neumann et al.， 
1992 ). The occurrence of scarring, hyper-pigmentation and hypo-
pigmentation after laser treatment was uncommon in comparison with 
that reported previously from the green light of argon laser (Pickering et 
al., 1990 )• The histological findings of the port-wine stain after 
irradiation by the copper vapour laser showed selective damages to the 
blood vessels similar to the tunable dye laser which emits yellow light at 
577 nm. The damage was the result of heat conduction by the 
oxyhaemoglobin，causing thermal necrosis of endothelial cells and 
localized thermal damage to perivascular fibrous connective tissue. 
There was no evidence of haemorrhage with a very low incidence of 
thrombosis or blood cell rupture ( Walker et al., 1989 )• 
It will be of great interest if the above mentioned phenomenon can 
be elaborated and applied to other tissues or organs in the human body. 
The present study is to investigate the possibility and safety of a new 
and high power model of copper vapour laser for the treatment of 
vascular lesions in the gastrointestinal tract, such as angiodysplasia, 
arteriovenous malformations, oesophageal and gastric varices. Among 
these vascular pathologies, oesophageal and gastric varices are of great 
importance, since varices may rupture and cause massive upper 
.gastrointestinal haemorrhage, and may be fatal especially in patients 
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with liver cirrhosis. The efficacy and safety of this new copper vapour 
laser needs to be determined before it can be applied in humans. 
This thesis consists of animal experiments and histopathological 
studies aimed at determining the efficacy and safety of the new high 
power copper vapour laser. 
(a) The major part of this thesis involved animals experiments, 
using groups of Sprague Dawley rats as animal model, to 
establish the safety limit of the copper vapour laser in the 
gastrointestinal tract. The experiments were set up to 
determine the time and power needed to perforate the gastric 
wall of rats with continuous application of the copper vapour 
laser. The thickness of the each rat's gastric wall was 
measured in advanced. 
(b) Histopathological studies to examine the damage in the rat 
stomach caused by laser treatment with varying time and 
power setting of the laser. 
(c) To demonstrate the effects of the copper vapour laser on blood 
vessels in rats, using Sprague Dawley rats' mesenteric vein as 
the model, to study the efficacy of laser treatment in 
obliteration of the blood vessels. 
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ABSTRACT 
Copper vapour laser with yellow beam wavelength at 578 n m was 
applied in the treatment of vascular lesions, such as the port-wine stains 
of the skin and the cavernous haemangiomas in the oral cavity. 
Satisfactory results proved its efficacy. application of the 
copper vapour laser for the treatment of the vascular anomalies in the 
gastrointestinal tract remains uncertain. Experiments using Sprague 
Dawley rats as animal model, was set up to test the safety and, if 
possible, the treatment dose for the copper vapour laser in the 
gastrointestinal tract. The results obtained show potential dangers in the 
perforation of vessels and unpredictable perforation of the rats stomach. 
And thus the author discourage the usage of the copper vapour laser in 
the gastrointestinal tract for the treatment of vascular anomalies like 
esophageal varices. 
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CHAPTER 1 : INTRODUCTION 
Copper vapour laser with yellow light wavelength at 578 n m has 
been used to treat superficial vascular lesions, such as port-wine stains, 
telangiectasia, spider naevi and also cavernous haemangiomas in the 
oral cavity. It gives satisfactory improvement in most patients ( Tong et 
al.，1993; Walker et al., 1989; Pickering et al.，1990; Neumann et al.， 
1992 ). The occurrence of scarring, hyper-pigmentation and hypo-
pigmentation after the treatment was low in comparison with that 
reported previously from the green light of argon laser ( Pickering et al., 
1990 ). The histological findings of the port-wine stain after irradiation 
by the copper vapour laser showed selective damages of blood vessels 
similar to the tunable dye laser which emits yellow light at 577 nm. The 
damage was the result of heat conduction from the oxyhaemoglobin, 
causing thermal necrosis of endothelial cells and thermal damage to 
localized perivascular fibrous connective tissue. There was no evidence 
of haemorrhage and only very little thrombosis or blood cell rupture 
occurred (Walker et al” 1989 ). 
It will be of great interest if the above mentioned phenomenon can 
be elaborated and applied to other tissues or organs in the human body. 
The present study is to investigate the possibility and safety of the use of 
a new and high power model of copper vapour laser for the treatment of 
vascular anomalies in the gastrointestinal tract, such as angiodysplasia, 
arteriovenous malformations, oesophageal and gastric varices. Among 
these vascular anomalies, oesophageal and gastric varices are of great 
importance, since these varices may rupture and cause massive 
haemorrhage in the upper gastrointestinal tract, and may leads to a fatal 
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result especially in patients with liver cirrhosis and Child's C liver 
disease. The efficacy and safety of the use of this new copper vapour 
laser needs to be determined before its general and endoscopic 
application in humans. 
This thesis is composed of animal experiments and 
histopathological studies aiming to determine the efficacy and safety of 
the new high power copper vapour laser. These are : 
(a) The major part of this thesis involved the animals 
experiments, using groups of Sprague Dawley rats as animal 
model, to establish the safety use of the copper vapour laser in 
the gastrointestinal tract. The aim was to determine the time 
and power needed for the perforation of the gastric wall of rats 
under the continuous exposure to the copper vapour laser. 
The thickness of the each rat's gastric wall was measured in 
advanced; 
(b) Histopathological studies to determine the effects by varying 
the time and power of the laser exposure at different time 
interval before killing the rats; 
(c) Also, to document the immediate histological effects of the 
copper vapour laser on vascular tissue in rats, using Sprague 
Dawley rats' mesenteric vein as model, aiming at the 
obliteration of vessels. 
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CHAPTER 2 : LITERATURE REVIEW 
2.1. The History of Laser 
The chronology of maser and laser history can be considered as 
starting in the early of this century with the so called pre-maser period 
which can be counted from 1917 to 1952. Then it was followed by the 
period from 1953 to 1959 which maser was developed. And from 1960 
to 1961，was the period of the development of the laser. After the year 
1962，with the advances in science and technology, the development of 
the laser was progressing through the present day. 
2.1.1 Pre-Maser History (1917 -1952) 
The basic concepts of maser/laser devices were first proposed by 
Albert Einstein in his classic publication "Zur Quantum Theorie der 
Strahlung" in 1917 ( Einstein 1917 ). The fundamental concepts of 
stimulated emission, stimulated absorption and spontaneous emission 
were speculated for the first time. These basic theories provided the 
foundation for the development of today's lasers. In that publication 
Einstein stated that electrons in an atom are generally in the ground 
state with no readily available energy. Energy may only be added to 
the atom in certain well-defined amounts, and the atom is said to be 
excited. W h e n an atom is in an excited state, i.e. energy is absorbed, 
it may be stimulated to emit a photon, and this process occurs with 
the same probability as absorption from the lower state. Since the 
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stimulation and the emitted photon turn out to be identical in every 
way, chain reactions are thus developed and trains of identical 
photons thus emitted. 
2.1.2. The Development of the Maser (1953 • 1959) 
Nearly forty years after Einstein's work, Joseph Weber published 
an article in 1953，suggesting the possibility of micro-wave 
amplification in a two level atomic media by the process of 
population inversion ( Weber 1953 ). The next year in 1954，C.H. 
Townes and his students at Columbia University, published the first 
paper announcing the generation of a coherent micro-wave beam 
operating at 23,870.14 MHz. This beam was developed from the 
inverted population of the two levels in ammonia ( Gordon et al.， 
1953 ). It was the Townes' group that coined the acronym "maser" 
meaning Microwave Amplification Stimulated Emission of Radiation. 
In 1958，Townes and Schawlow published the historic paper 
which proposed the extension of the maser principle to infrared and 
visible regions of the spectrum ( Schawlow et al., 1958 ). This article 
marked the beginning of the race to build the first optical maser. The 
term 'laser' was not coined until later, the T for 'light' replacing the'm' 
for 'microwave'. 
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2.1.3. The Development of the Laser (1960 • 1961) 
2.1.3.1. The First Laser Device Developed 
By 1959，the significant achievements of microwave 
amplification by stimulated emission had been reported ( 
Schawlow et al.，1958 ). Research work then began on extending 
this principle into the optical frequency range. 
T.H. Maiman, a research scientist at Hughes Aircraft Research 
Laboratories, used ruby crystals as a laser material. On July 7， 
1960, he made publication of his discovery of the first ruby laser in 
Nature ( Maiman 1960 ). His device produced a 400 millijoule 
pulse of coherent light at 694.4 n m lasting for only several hundred 
microseconds. 
2.1.3.2. The First Gas Laser Developed 
Within six months after the announcement of Maiman, the 
first "gas laser" was developed and announced by a Bell Telephone 
Laboratories research team, using a mixture of helium-neon gas 
operated at an infrared wavelength of 1150 nm ( Javan et al., 1961 
)• 
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2.1.3.3. The MQ-SwitchM Introduced 
In that time, the laser output of both the ruby laser of Maiman 
and the other gas lasers displayed definite relaxation oscillations 
which were somewhat mysterious at the time and were referred to 
as laser "spikes". Then, in 1961，McClung and Hellwarth 
announced the discovery of a device known as "Q-switching"， 
which controlled the energy stored in the laser media to release in 
one single giant pulse rather than spikes ( McClung et al.，1962 ). 
In another word, even those lasers with lower energy generated, the 
power can still be increased and magnified. 
2.1.4. Expanding the Laser Concept (1962 -1966) 
2.1.4.1 The first experiment of the laser in space 
Smullin and Fiocco, and their colleagues at Massachusetts 
Institute of Technology ( MIT ) conducted the much heralded 
experiment of directing the laser at the moon ( Smullin et al., 1962 
)；and this experiment also initiated the military and space 
applications of the laser. 
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2.1.4.2. More new laser system introduced 
Between the late 1962 and early 1963，several new laser 
systems were announced. For example, the first report of laser 
action in Noble gas by Patel ( Patel et al., 1962 ), the first operation 
of the Helium-Neon laser at 632.8 n m visible red transition; the 
first operation of the Nitrogen ultraviolet gas laser at 337.1 nm; the 
first visible laser transition from a pulse carbon monoxide gas laser 
and the operation of the first liquid laser using trivalent europium 
in a chelate active medium (Eckhardt et al., 1962 ). 
2.1.4.3. The discovery of the ion laser principle 
In 1964，Bell announced the discovery of the ion laser which 
produced a visible transition at 615.0 n m by using mercury vapour 
as the active media ( Bell 1964 ). This implicated the discovery of 
the use of heavy metal vapour as a laser media. 
2.1.4.4. The first high power continuous wave laser 
introduced 
In 1964, Patel and his associates at the Bell Telephone 
Laboratories discovered the carbon dioxide-nitrogen laser ( Patel 
1964 ). The notable characteristic of the device is its high 
efficiency, and it is one of the most important single developments 
in the history of laser systems. 
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2.1.4.5. Expanding the engineering concepts of laser systems 
Although the ruby laser was the first device developed, 
extension of high power solid materials for laser action has not 
brought many new additions. Therefore, in 1965，the use of 
neodymium ions doped in crystals of calcium tungstate and 
yttrium-aluminium-garnet were two significant developments ( 
Woodbury 1966; Duguay et al.，1967 ). 
2.1.4.6. The medical laser 
After 1962，people ( Kapany et al., 1963; Flocks et al., 1964; 
McGuff et al., 1965 ) started to investigate the use of laser in 
medical treatments were attempted. This retina of the eye is an 
obvious target for the application of this technology as laser light 
can be directed to the retina through the eye's own refractive 
system. By using the ruby laser, ophthalmologists were satisfied 
with the retinal burns which could be produced in preliminary trials 
on rabbits and cats ( Kapany et al., 1963 )• Various workers had 
also applied laser to human eye in an attempt to repair peripheral 
retinal pathologies such as holes and tears ( Flocks et al., 1964 )• 
And these treatments represented the first successful surgical 
application of laser. Then, in 1965 surgeons began to investigate 
the ruby laser's ability to destroy malignant tumours in animals ( 
McGuff et al., 1965 ). And Goldman reported some success about 
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a series of patients treated for superficial malignancies at various 
laser pulse energy (Goldman et al.，1965 ). 
2.1.5. New Laser Development (1967 • at present) 
The first multi-wavelength ( broad spectrum ) liquid laser was 
introduced in 1967 by Sorokin and his research associates in the 
research division of the International Business Machine ( I B M ). The 
device used organic dyes which were capable of producing red, green, 
or yellow laser lines ( Sorokin et al., 1967 ). 
There were several notable laser achievements during 1968，for 
instance, the first continuous tunable diode laser was announced by 
Hinkley and his associates at Massachusetts Institute of Technology ( 
Hinkley et al., 1968 )• In their device, the output frequency of the 
diode was controllable over a range of 50 gigahertz by changing the 
electric current which powers the diode. 
2.2. Basic Laser System 
There are features which are common to the configuration of all 
laser systems ( Fig. 2.1. ). For example, there must be an active laser 
media, a external source act as excitation energy and also a pair of 
mirror which are placed at the two end of the active laser media and 
aligned in parallel. 
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Figure 2.1. The Basic Laser System 
2.2.1. The Active Laser Media 
The active laser media can be either a solid, liquid, gas, or 
junction between two dissimilar metals, which is capable ( because of 
its atomic and/or molecular makeup ) of sustaining stimulated 
emission. 
2.2.2. The Source of Excitation Energy 
A redistribution of the number of atoms or population inversion 
which normally exists in certain atomic energy levels of the laser 
media is required to generate a laser beam. This process needs an 
external source as an excitation energy often called the "pump 
energy". Electrical currents, flash lamp ( optical pumping ), chemical 
reaction, neutral atom discharge and ionization can all act as a kind of 
pump energy to achieve population inversion. 
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2.2.3. A Febry-Perot Interferometer 
A Febry-Perot Interferometer is a pair of mirrors which are 
aligned parallel to one another. In the case of laser, one mirror is 
placed at each end of the active laser media. Usually one mirror is a 
total reflector, and the other is a partial reflector ( The partial reflector 
allows part of the laser beam which is generated within the active 
media to pass through the interferometer )• 
2.3. Basic operational principles of laser 
All laser operates on the same physical principle. The excitation 
energy is vigorously supplied to the active media to produce the 
condition of population inversion. In this condition, more atoms or 
molecules of the laser media are found to be in the excited state 
energy level rather than in the lowest "ground state" level- This 
condition is contrary to the normal population of state of a system in 
thermal equilibrium. After energy is absorbed, an atom spontaneous 
returns to its ground state and thereby liberates the absorbed energy as 
photon. This process is referred to as spontaneous emission of 
radiation. 
The unique feature of a laser device lies in the fact that because 
of the population inversion, the energy released may be accomplished 
by the process known as stimulated emission. In this case a photon 
released by one excited atom will cause or stimulate an excited atom, 
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it may encounter in its path to also release a photon of excess energy. 
The result of this interaction is the combination of two photons with 
identical coherence properties ( phase relationships ) such that they 
add completely together to produce a beam of twice the intensity. As 
the beam progresses through the excited laser media, its amplitude 
will be rapidly increased while its coherence properties remain 
unaltered. Upon reaching the total reflection mirror the beam 
direction is completely reversed, thus allowing another pass through 
the excited laser media so that the beam may be further amplified. 
Upon reaching the partial reflecting mirror, a portion of the beam 
escapes. This escaping portion is the active emission from the laser. 
The process will continue for as long as sufficient pump energy is 
supplied to the laser media. 
2.4. Characteristics of Laser Radiation 
There are six properties common to the beam emitted from all laser 
types and are factors which, when combines together distinguish laser 
outputs from other sources of radiation: 
1. A nearly single frequency operation of low bandwidth ( i.e. an 
almost pure monochromatic light beam )• 
2. Emission of a slowly spreading beam with well defined wave 
fronts. 
3. A beam of enormous intensity. 
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4. A beam which maintains a high degree of temporal and spatial 
coherence. 
5. A beam that is, in many laser devices, highly plane polarized. 
6. A beam with enormous electromagnetic field strengths. 
These unique properties may be attributed to the fundamental 
physical laws which govern the process of stimulated emission. These 
laws demand that all of the emitted photons have the same wavelength 
and the same coherence characteristics as the photon or photons which 
initiate the emission process. As a result, a highly coherent beam is 
produced with very small beam spreaded. 
2.5. Laser Reactions in Living Tissue 
2.5.1. Laser Interactions with the Eye 
Laser interaction with ocular tissues require special attention 
since the cornea, lens, and the vitreous cavity are quite transparent to 
the visible and near-infrared radiation, that is, between 400 n m to 
1,400 nm. Therefore, energy from lasers operating between these 
ranges will only be absorbed by the retina. The near-ultraviolet with 
wavelength 300 to 400 n m is almost totally absorbed in the normal 
crystalline lens, and the cornea surface will absorb the energy with 
wavelength at 10,600 n m from the C O 2 laser and wavelengths below 
300 n m from the excimer lasers. 
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As a matter of fact, light is focused after passing through the 
cornea and the lens, and will increase the irradiance at the retina with 
the irradiation concentrated by a factor of 100,000 and which may 
cause damages to the retina of the eye with loss of vision. And thus 
makes the eye the unique organ of concern for laser safety. 
2.5.2. Laser Interaction with the Skin and its Appendages 
The skin and its appendages, hair and nails are the most 
accessible tissues to laser irradiation, especially those operating with 
wavelengths in the visible light. In general, laser radiation incident 
upon the surface of skin and its appendages is reflected, absorbed and 
transmitted. When the frequency is between 300 n m to 1,000 nm, up 
to 99% of the radiation penetrating the skin will be absorbed in at 
least the 3.6 m m of the tissue. And the absorption by these structures 
is highly related to the amount or concentration of melanin and also to 
the degree of vascularity. From the safety point of view, the damage 
of the skin and its appendages by the commonly used medical lasers 
is usually a small burn, and thus it is of less concern when compare 
with the eye. 
2.5.3. Laser Interaction with other tissues 
Different medical lasers may have different effects on a variety 
of tissues. Before a new laser can be applied in medicine and surgery, 
an in-depth study of the effects of the incident laser beam is required. 
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Those effects including the absorption of the laser irradiation by the 
tissue or the optical effect, the redistribution of the absorbed energy 
by heat conduction, chemical reactions, and mechanical forces. In 
different laser surgical procedures or treatment protocols, depending 
upon laser power, exposure duration, and wavelength, one of the 
following different laser-tissue interactions may occur. 
1. Photocoagulation: 
this is the most widespread phenomenon employed in the 
surgical applications of medical lasers. In this process, all 
proteins, enzymes，and other critical biological molecules in 
tissue are heated to temperature well above 50°C with a 
resultant tissue denaturation occurring almost immediately. 
Photocoagulation is used to prevent or control blood loss 
when surgically incising heavily vascularized tissues like the 
liver, the vaginal wall, the nasal mucosa, the larynx, etc.. 
Also, to coagulate the retina, the trabecular meshwork, and the 
ciliary body of the eye when used in ophthalmology. 
2. Photothermal Ablation ( Vaporization): 
it is occurred when the temperatures in excess of 100°C 
when the tissue water boils. The production and emission of 
steam results in the removal of biological tissue in the form of 
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microscopic particles. Photovapourization is used for incision 
and removal of diseased tissue such as tumours. 
3. Photochemical Ablation (Photoablative decomposition): 
it is a description on the unusually clean-cut incisions 
which are the effects by short-wavelength ultraviolet pulsed 
excimer lasers. The thermal and thermomechanical 
interaction is relatively small and the zone of thermal 
interaction is limited in the incision wall. The explosive force 
by which the molecules are thrown off the surface results from 
some combination of photochemical breakdown and high 
surface temperatures. 
4. Photodisruption: 
it is coined with the ophthalmic Nd:YAG Q-switched or 
mode-locked lasers that produced ultrashort pulses. And 
which are used to incise transparent or nearly transparent 
membranes in the eye. 
5. Photochemical Interactions: 
in every instance of laser-tissue interactions there are 
competing thermal and photochemical damage mechanisms. 
And in many instances, photochemical effects are dwarfed by 
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temperature rises sufficient to cause thermal denaturation of 
tissue. However, under low dose rates or low irradiance, 
photochemistry may be the dominant mechanism. In this case, 
energy is delivered sufficiently slowly so that heat is 
conducted away from the interaction site, and normal 
temperatures are maintained and photochemical effects may 
induce biological changes. There are some beneficial 
photochemical interactions such as vision and the production 
of vitamin D in the skin. And there are also well-known 
adverse photochemical effects, such as erythema and 
photokeratoconjunctivitis ( welder's flash ). Photochemistry is 
the primary interaction mechanism in photochemotherapy or 
photodynamic therapy. With this method, a photosensitizing 
drug is introduced into biological tissue which is then exposed 
to the incident laser radiation, and thus elicits the desired 
biological response. This photosensitizer may then produce a 
toxic side-effect in the target cells. An example of 
photochemotherapy is the use of hematoporphyrin derivative ( 
H P D ) to treat tumors. 
I P. 19 
2.6. Thermal Effect of Laser Irradiation of Living Tissues 
Thermal effect is the most important aspect of laser interaction in 
living tissues. The thermal reaction of absorbed radiant energy in 
tissues is strongly dependent upon both duration and the area of the 
exposure. 
The basic mechanisms of thermally induced tissue destruction 
result from the denaturation of cell protein, interference with basic cell 
metabolism and secondary effects such as interference with vascular 
blood supply. 
When continuous wave laser energy is focused into tissues at a 
high incident power density, the basic tissue reaction is thermally 
induced coagulation necrosis, which is followed by vaporization 
ablation, and, in some specific cases, vasoconstriction. The temperature 
rises in the tissue volume described by the focal region of the laser beam 
will be in the order of 100°C. And the surrounding tissues may also 
experience a temperature rise which can cause biological cellular death. 
When energy is delivered by prolonged exposure on the same area, the 
cut becomes deeper and the region of cellular death expands. 
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2.7. Medical lasers and their applications 
There are more than hundreds of different kind of lasers available 
today, and many of them has been used as medical or surgical 
instruments. The followings are the most common laser devices in 
routine use under investigation. 
2.7.1. Neodymium-doped yttrium-aluminium-garnet ( Nd:YAG ) 
laser 
N d : Y A G laser is the most powerful continuous wave laser, 
operating in the infrared range at wavelength 1,060 nm. Having the 
characteristics of nonspecific tissue absorption and three to four 
millimeter's penetration depth, the N d : Y A G laser has been used as a 
coagulator and vapourisor. Different devices is being used in 
ophthalmology, oncology and also in the haemostasis for 
gastrointestinal bleeding. 
2.7.2. Argon laser 
Argon laser is also a continuous wave laser, but operating in the 
blue and blue-green spectrum at wavelengths of 476.5 nm, 488 n m 
and 514.5 nm. The most common usage of argon laser is in 
ophthalmology, and it has also been used in dermatology to treat 
some superficial skin lesion like the port-wine stains ( Apfelberg et 
al.，1976，1977，1980). 
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2.7.3. Carbon dioxide laser 
Carbon dioxide laser is a continuous wave laser, operating in the 
far-infrared spectrum at a wavelength of 10,600 nm. The laser beam 
can penetrates 0.1 to 0.2 m m of tissue. Since the long wavelength 
output is strongly absorbed by water that when a laser beam is 
focused to a spot of tissue of 1 m m diameter, the tissue will be 
vapourized. With this characteristic, the carbon dioxide laser is used 
as a cutting scalpel in general surgery ( Ben-Bassat et al., 1976 )，and 
also used in gynaecology, otonasolaryngology and neurosurgery. 
2.7.4. Tunable dye laser 
Tunable dye laser can be tuned over a broad range of 
wavelengths. The 'dye' in a dye laser is an organic dye such as those 
used in colour fabrics, food or other material. 
It is commonly used wavelength at 577 n m with yellow light for 
the treatment of the port-wine stains in dermatology, others also been 
used in ophthalmology and in the photoradiation therapy and for 
lithotripsy of urinary and biliary stones. 
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2.7.5. Gold Vapour Laser 
Gold vapour laser is one of the metal-vapour lasers. It operates 
in a continuous wave mode at a wavelength of 627.8 nm. Since this 
line lies close to the absorption peak of haematoporphyrin derivative ( 
H P D ), the gold-vapour laser is being used in the photoradiation 
therapy ( P R T ) or photodynamic therapy. 
2.7.6. Copper Vapour Laser 
Copper vapour laser is said to be the most successful cyclic 
metal-vapour laser operating at wavelength 510 n m and 578 nm. This 
device was first reported by Walker et al. in 1966. The importance of 
the copper-vapour laser in surgery is its high average power which 
offers in the blue-green and yellow line. In principle, it can be used 
as a direct substitute for the argon laser. The copper-vapour yellow 
line is virtually in exact coincidence with the absorption peak of 
oxyhaemoglobin, a factor which should prove useful in the treatment 
of vascular lesions in dermatology and also in ophthalmology. 
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2.8. Port-wine stains 
2.8.1. Pathology of port-wine stains 
Port-wine stains ( P W S s ) are red-coloured cosmetic disorders 
and benign congenital vascular malformations involving mature 
capillaries of the skin. These "haemangiomas" are members of a large 
group of congenital lesion termed nevus flammeus, which commonly 
involved the forehead, face, occiput and nuchal regions. The central 
abnormalities characterizing port-wine stains are an increase in vessel 
number and ectasia. Vessel number is high in the immediate 
subepidermal area and then rapidly diminishes. The mean depth of 
these is 0.46 土 0.17 m m ( Barsky et al.，1980 )• Before 1981，the 
traditional treatments for the port-wine stains include freezing, 
abrasion and laser exposures. And all these treatments caused 
nonspecific necrosis of the upper dermis and epidermis ( Greenwald 
etal., 1981). 
2.8.2. Treatment of port-wine stains by lasers 
2.8.2.1. Treatment of port-wine stains by argon laser 
The continuous wave argon ion laser, operate at wavelength 
488 and 514.5 nm, was one of the first lasers being reported and 
was the most commonly used laser to treat the patients with port-
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wine stains before the year 1985( Solomon et al., 1968; Apfelberg 
et al., 1976 )• The immediate optical effect after argon laser 
treatment was blisters formation at the treated area giving a white 
and gray discolouration. Since the haemoglobin in the erythrocyte 
absorbs the blue-green laser light, the radiant energy emitted from 
the laser is transformed into heat energy, which coagulates blood 
vessels up to 0.5 m m in diameter. Adjacent skin appendages are 
relatively less damaged and are able to participate in the 
reconstruction of normal epidermis. Histologically, the injury to 
the upper dermis is rapidly healed which leaves essentially normal 
epidermis and diffuse mild upper dermal fibrosis ( Apfelberg et al., 
1979，1981 )• 
2.8.2.2. Treatment of port-wine stains by dye laser 
Treatment of the port-wine stains by using the dye laser 
operating at wavelength 577 n m was carried out after the 
investigation on the nature and characteristics of the port-wine 
stains. Since port-wine stains are haemangiomas due to the 
presence of large numbers of ectatic blood vessels in the superficial 
dermis, and the concentration of the haemoglobin is comparatively 
higher than the normal skin. The dominant haemoglobin species 
even in the cutaneous venous blood is in the oxygenated form， 
which possesses several strong absorption bands in the visible 
spectrum, allowing a wider choice of potentially useful 
wavelengths. Therefore, intravascularly, haemoglobin is clearly 
the logical choice of target for laser treatments. By knowing that 
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the average molar concentration of haemoglobin in whole blood is 
approximately 2.1 x 10_3 M , and the molar extinction coefficient 
for Hb〇2 at the 418 nm, 542 n m and 577 n m bands are 131,000, 
14,200 and 15,200 1 mole-1 cm"l, respectively, the dye laser at 540 
n m ( Hulsbergen Henning et al., 1983 ) and 577 n m were used as 
choices for treatment of the port-wine stains ( Anderson et al., 
1981; Hulsbergen Henning et al., 1984 ). In their experiments, they 
found that selective vascular damage without destruction of 
epidermal and dermal tissues is possible. And the clinical effects 
were completely due to direct absorption of light by the 
erythrocytes which carried the haemoglobin. Because heat 
conduction is absent, absorption of microsecond pulses laser light 
causes
 M
steam"-formation inside the blood vessel, leading to a 
large, local intravascular pressure which causes tearing. These 
tearing is insufficient to cause an obliteration of the dilated vessels. 
Hence, laser pulses of the order of millisecond can probably cause 
sufficient vessel wall damage which leads to an obliteration ( 
Hulsbergen Henning et al., 1984 ). 
2.8.2.3. Treatment of port-wine stains by carbon dioxide laser 
There were some reports in using the carbon dioxide laser in 
the treatment of the port-wine stains ( Ratz et al., 1982; Buecker et 
al., 1984; Tan et al., 1986; van Gemert et al., 1987 )• Since the far-
infrared-emitting carbon dioxide laser is strongly absorbed by 
water, the optical and thermal penetration of the laser can be 
minimal, with damage extending only 30 to 50 jurn from the skin 
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surface. The carbon dioxide laser can be used to seal off the 
vascular network in the superficial dermis only after coagulation or 
vaporization of the entire epidermis. Because the chromophore for 
the carbon dioxide laser is water and not oxyhaemoglobin, damage 
caused by this laser is histologically nonspecific. Thus, 
hypertrophic scars occur in 9 % of patients, and there is a fair to 
poor response in 27% (Tan et al., 1986 )• 
2.8.2.4. Treatment of port-wine stains by copper vapour laser 
The copper vapour laser, operate at 578 n m yellow light, has 
been reported to treat patients with port-wine stains in the recent 
years ( Walker et al., 1989; Pickering et al., 1990; Neumann et al., 
1992 ). Laser light focused on a quartz optic fibre of 1 m m in 
diameter was used, which was scanned by hand approximately 2 
m m above the skin surface, producing a 1.3 m m diameter spot. 
Histological study after treatment shown that the copper vapour 
laser, like the tunable dye laser operate at 577 nm, produces 
damage that is specifically concentrated on the ectatic vessels, 
rather than non-specifically throughout the dermis. And the 
occurrence of scarring, hyper-pigmentation and hypo-pigmentation 
was low in comparison with that reported from the green light of 
the argon lasers ( Walker et al., 1989; Pickering et al., 1990; 
Neumann et al., 1992 )• 
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2.9. Laser Therapy in the Gastrointestinal Tract 
In the early 70's in 1971，Dr. Goodale, a surgeon at the University 
of Minnesota described the first application of a laser to the 
gastrointestinal tract. H e performed open surgery to his patient and a 
C O 2 laser was used to coagulate diffuse bleeding from the stomach in an 
attempt to avoid gastric resection. 
In 1973, Dr. Peter Kiefhaber at the University of Munich in 
Germany performed the first dog experiments using an argon laser to 
coagulate intestinal bleeding. The following year, in Februa^ 1974，Dr. 
Richard Dwyer performed the first argon treatment of a human being 
with an endoscopically delivered system in Los Angeles. T w o years 
later, in 1976，Dr. Peter Kiefhaber was the first person in the world to 
coagulate a bleeding patient, using a 1,064 micron neodymium: Y A G 
laser. Then in July 1985，Dr. Richard Dwyer was again first in treating 
tumors and bleeding using a 1,319 micron neodymium-YAG laser ( 
Dwyer 1986). 
In the United States, since Dr. Richard Dwyer first used endoscopic 
laser therapy to treat acute gastrointestinal bleeding, there has been 
exponential growth in the use of laser endoscopically. In 1979，only 3 
centers in the United States were using laser for the treatment of 
gastrointestinal diseases, and six years later there were more than 300 
centers using lasers. The use of the modality continues to expand, and 
different application of the lasers in the gastrointestinal tract are as 
follow: 
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I. Coagulation 
A) Acute haemorrhage 
1. Active bleeding 
2. Recent bleeding (e.g. visible vessel) 





A) Neoplastic disease 
1. Palliation 
2. Curative treatment 
3. Ancillary ( e.g. placement of esophageal prosthesis) 
B) Benign stricture or web 
C) Biliary disease 
1. InfUndibulotomy 
2. Strictures 
3. Lithotripsy of biliary stone 
D) Cyst drainage 
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2.10. Esophageal varices 
Varicose veins are abnormally dilated and tortuous veins. 
Esophageal varices are dilated and elongated oesophageal veins which 
develope as a complication of portal hypertension. They are an 
important cause of upper gastrointestinal bleeding, particularly in 
alcoholics with cirrhosis of the liver. Bleeding from oesophageal 
varices carries a mortality of 30-50% ( Sabiston，1986). 
2.10.1. Etiology of oesophageal varices 
Oesophageal varices occur as a result of portal hypertension, 
which is caused by obstruction to the portal blood flow to the inferior 
vena cava via the hepatic veins. The sites of obstruction may be 
intrahepatic or extrahepatic. Intrahepatic obstruction can be pre-
sinusoidal or post-sinusoidal. Peri-portal fibrosis or Schistosomiasis 
are the pre-sinusoidal causes，where as cirrhosis, haemochromatosis, 
Wilson's disease and congenital hepatic fibrosis are post-sinusoidal 
causes. Extrahepatic obstructions can be classified into inflow 
obstruction, outflow obstruction or no obstruction. Portal vein 
thrombosis, portal vein compression and congenital portal vein 
obstruction belong to the group of inflow obstruction. Hepatic vein 
thrombosis ( Budd-Chiari syndrome )，Tricuspid incompetence and 
right heart failure are the causes of outflow obstruction, where arterio-
portal venous fistula has no mechanical obstruction. 
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2.10.2. Pathology of oesophageal varices 
Microscopically there is irregular thinning of the vein wall, as 
well as areas of compensatory thickening and thromboses. In 
addition, there are deformities of the valves; these are predominantly 
secondary to the dilatation of and thromboses in the veins which 
worsen the varicosities. 
2.10.3. Diagnosis of esophageal varices 
In most patients admitted to the hospital with upper 
gastrointestinal haemorrhage, the diagnosis of bleeding esophageal 
varices depends on affirmative answers to three questions: 
1. Does the patient have liver cirrhosis? 
2. Does the patient have portal hypertension and esophageal 
varices? 
3. Are the varices the site of bleeding? This require exclusion 
of other lesion such as duodenal or gastric ulcer, gastritis, or 
hiatus hernia. 
Answers to these questions usually can be obtained within a few 
hours of the patient's admission to the hospital by means of an 
organized diagnostic plan that includes some, if necessary all, of the 
following steps: 
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1. History and physical examination. 
A history of chronic alcoholism, hepatitis, jaundice, 
previous bleeding episodes, melena, abdominal swelling, 
edema, and mental abnormalities, in the absence of symptoms 
of peptic ulcer suggest the diagnosis of cirrhosis. The most 
important physical findings are hepatosplenomegaly, spider 
angiomata, palmar erythema, dilated abdominal veins, muscle 
wasting, jaundice, ascites, edema, and neurologic signs such 
as tremor and asterixis. In many patients, not all of these 
classic signs are present. Confirmation of gastrointestinal 
bleeding by aspiration of the stomach through a nasogastric 
tube and by gross and chemical examination of the stool for 
blood is essential for early diagnosis and should be part of the 
physical examination. 
2. Blood studies. 
Blood samples for typing and cross-matching and for 
haematological studies should be drawn on admission. The 
initial studies include a complete blood count, liver function 
tests, urea nitrogen, electrolytes, pH, blood gases, and blood 
alcohol level. 
I P. 32 
3. Fibre-optic endoscopy. 
Fibre-optic endoscopy will demonstrate the presence of 
oesophageal varices and differentiate variceal bleeding from 
peptic ulcer or multiple gastric erosions, both of which are 
common in patients with cirrhosis. If initial endoscopy is 
hampered by the presence of blood or clots in the stomach or 
oesophagus, lavage with an Ewald tube may be required. 
Accurate assessment of the size and extent of varices during 
acute bleeding is limited by the degree of fluid resuscitation. 
In 10 to 20 per cent of patients, the acute bleeding may be 
from a site other than varices, and every attempt should be 
made to exclude peptic ( gastric or duodenal ) ulcer bleeding. 
Bleeding due to gastritis in patients with portal hypertension 
should be considered and managed accordingly. 
2.10.4. Treatment of esophageal varices 
In all cases of active bleeding esophageal varices，endoscopy 
should, if possible, be done as soon as possible before instituting any 
other treatment. The immediate treatment of haemorrhage other than 
endoscopy, is blood transfusion. Absorption of nitrogenous products 
from the bowel is reduced by emptying of blood from the colon by 
means of an enema, or by giving oral antibiotics like neomycin to 
reduce bacterial decomposition of blood in the gut. Dietary protein is 
withheld and nourishment maintained by means of glucose given by 
mouth or intravenously. In fitter subjects, preparations are made for 
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emergency surgery or endoscopy. The haemorrhage can be controlled 
either by: 
1) direct pressure on the varices using a Sengstaken tube 
which is introduced through the hose into the oesophagus 
and across the cardia, and then inflated，or; 
2) intravenous Pitressin or Somatostatin which produce a 
marked reduction in portal venous pressure and temporary 
cessation of bleeding by mesenteric arteriolar constriction ( 
Sung JY，1993 ). 
2.10.4.1. Surgical treatments of esophageal varices 
Surgical treatments for the esophageal varices may be either a 
decompressive shunt or an ablative procedure. Decompressive 
shunting operation include the portacaval shunt or the 
portasystemic shunt, selective distal splenorenal ( D S R ) shunt and 
interposition mesocaval shunt. Operations other than shuntings 
like the Sugiura operation, the trans-thoracic or trans-esophageal 
ligation of varices are alternative methods. 
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2.10.4.1.1. Portacaval shunt 
In 1877，Nicolai Eck published the first paper on portacaval 
shunt performed on eight dogs. The first reported portacaval shunt 
in man was done by Vidal in 1903. The portacaval shiunt was made 
by an end-to-side anastomosis of the portal vein to the inferior vena 
cava, after ligation and transection of the portal vein at the 
proximal end near the liver. 
2.10.4.1.2. Selective distal splenorenal (DSR ) shunt 
The distal splenorenal ( D S R ) shunt was introduced by 
Warren and his colleagues in 1974，and in an attempt to reduce the 
operative mortality in the emergency situation. The operation is 
technically more difficult than the Portacaval shunt operation. It is 
done by ligation and transection of the umbilical vein, the coronary 
vein，the gastroepiploic vein and the splenic vein, with an end-to-
side anastomosis of the splenic vein to the renal vein. Therefore, 
all the blood from the spleen and the esophageal varices will enter 
the inferior vena cava via the renal vein, and blood from the 
superior and inferior mesenteric veins will enter into the liver via 
the portal vein. Thus, the esophageal varices were selectively 
decompressed ( Warren et al., 1974 ). 
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2.10.4.1.3. Interposition mesocaval shunt 
The interposition mesocaval shunt is similar to the portacaval 
shunt. Ligation of the portal vein is not needed, the site of 
anastomosis is at the mesenteric vein just beneath the junction to 
the splenic vein. The anastomosis may either be a side-to-side 
anastomosis or by a H-graft. These will provide a total portal 
venous decompression, and converting the portal vein to hepatic 
outflow. But, this operation and the end-to-side portacaval shunt 
do carry a significant risk of early or later liver failure secondary to 
loss of portal venous perfusion ( Drapanas et al., 1975 ). 
2.10.4.1.4. Sugiura operation 
The Sugiura operation is introduced by Sugiura and Futagawa 
in 1973，they described a rational concept of local non-shunt 
therapy for variceal haemorrhage by a combined two-stage 
procedure of extensive devascularization of the abdominal and 
thoracic oesophagus, esophageal transection, splenectomy, 
vagotomy, and pyloroplasty. In a later report involving 270 
patients treated by this operation，Sugiura and Futagawa reported a 
very low mortality rate, a low incidence of recurrent bleeding and a 
7-year survival rate of 82% with no encephalopathy occurred ( 
Sugiura et al.，1973 & 1977 ). 
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2.10.4.1.5. Trans-thoracic or trans-esophageal ligation of 
varices 
Transesophageal ligation of esophageal varices was first 
described by Boerema in 1949，but the reported experience with 
this procedure has not been large and was regarded as one of the 
emergency surgical procedure. 
2.10.4.2. Endoscopic treatment of esophageal varices 
With the improvement of the instruments and techniques, 
various methods for endoscopic treatment of esophageal varices 
and upper gastrointestinal bleedings are now available. These 
methods include topical, injection, mechanical and thermal therapy. 
Describe as follow: 
1. Topical 
A. Tissue glues 
B. Collagen 
C. Clotting factors 
D. Ferromagnetic tamponade 
2. Injection 
Variceal sclerosis 
, B. Nonvariceal sclerosis 
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3. Mechanical 
A. Surgical clips 
B. Sutures 
C. Balloons 




C. Heater probe 
D. Cryotherapy 
2.10.4.2.1. Endoscopic injection sclerotherapy 
Endoscopic injection sclerotherapy was first reported by 
Crafoord and Frenckner in 1939. The method involved injection of 
a certain amount of sclerosant, intravariceally or paravariceally 
with a needle injector introduced through a gastrointestinal 
endoscope. The sclerosant used may be 33% ethanol ( Snady, 1987 
)，absolute alcohol ( Sarin et al., 1988 )，0.3N saline ( Snady, 1987 
)，5% ethanolamine oleate ( El-Zayadi et al., 1988; Stringer et al., 
1989 )，1% or 2 % polidocanol ( Aethoxysclerol ) ( Jensen et al., 
1989 )，0.75% to 1.0% sodium tetradecyl sulfate ( Snady, 1987 )or 
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1-5% to 2.0% sodium morrhuate ( Cello et al., 1987; Snady, 1987; 
Henderson et al” 1990 )• 
2.10.4.2.2. Endoscopic ligation 
Endoscopic ligation of the esophageal varices was first 
described by Stiegmann and his colleagues ( Stiegmann et al., 1986 
). This treatment method needs a special device called the 
endoscopic ligation device ( E L D )，which can apply a elastic "O" 
ring onto the varix. The endoscopist approaches a varix and make 
contact between the varix and the end of the endoscopic ligating 
device，suction is then applied to draw the varix into the ligating 
chamber. Next, the inner cylinder is moved towards the endoscope 
by the operator who pulls a trip wire which is connected to it and 
run retrograde through the endoscope's working channel. This 
movement ejects the elastic "O" ring from the inner cylinder, 
capture and ensnare the esophageal varix. Usually, eight to twelve 
ligations can be applied to the varices in one endoscopic treatment 
session. This treatment is repeated at 7 to 14 day intervals until the 
varices are eradicated or reduced in size. Stiegmann ( Stiegmann et 
al., 1989 ) stated that endoscopic variceal ligation appears to be 
effective in both the emergent and elective treatment of esophageal 
varices. The overall success of 88% in the control of active 
variceal bleeding is slightly difference from those observed by 
Fleig ( 83% ) for the control of active bleeding by sclerotherapy ( 
Fleig W E et al., 1983 ). 
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2.10.4.2.3. Endoscopic laser therapy 
Endoscopic laser treatment in the human gastrointestinal tract 
was started in 1974 by Dwyer et al. ( 1976 ) and Fruhmorgen et al. 
(1976 ) with the use of argon laser. T w o years later, in 1976， 
Kiefhaber used the 10,600 n m neodymium:YAG laser to coagulate 
a bleeding lesion ( Kiefhaber et al., 1977 ). In 1985，Fleischer 
reported a double-blind, randomized controlled study which 
addressed the efficacy of endoscopic N d : Y A G laser therapy for 
controlling active haemorrhage from esophageal varices, however 
rebleeding was common ( Fleischer, 1985 ). In 1987，Kiefhaber 
published a report on twelve years' experience using endoscopic 
N d : Y A G laser treatment in the gastrointestinal tract. Kiefhaber 
stated that the problems of haemostasis by laser radiation without 
mechanical contact, such as heat dissipation of the absorbed energy 
by the flowing or spurting blood, screening effects of blood layers, 
creation of a solid thrombus, have not been solved by the 
wavelengths of carbon dioxide or argon lasers. And he claimed 
that the solution of the mentioned problems were pulses of 0.5 sec 
duration of a high power N d : Y A G laser having a power output of 
80-90 W . In his report, he stated that bleeding esophageal and 
gastric varices due to general or segmental portal hypertension 
have been stopped primarily by laser coagulation in 93%. And, 
rebleeding and in-hospital mortality were reduced markedly from 
66% to 26.8% by combination of paravariceal sclerotherapy 
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immediately after the acute bleeding had been stopped by pulsed 
N d : Y A G laser coagulation ( Kiefhaber, 1987 ). 
In the endoscopic N d : Y A G laser treatment of esophageal 
varices or spurting arterial bleeding ulcers, the surrounding areas 
have to be irradiated first to create tissue edema which compressed 
the feeding vessels, so that the bleeding source itself can be 
occluded more easily ( Kiefhaber, 1987 ). 
Although endoscopic laser treatment of the esophageal varices 
by the pulsed N d : Y A G laser has been claimed to be successful, it 
has not gained widespread acceptance. Laser instrumentation, 
technical difficulties, knowledge of laser physics and its tissue 
reactions, as well as the potential complication of iatrogenic 
rupture of the varix resulting in torrential haemorrhage may be the 
reasons. 
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CHAPTER ^ ； ANTMAL EXPFRTMFNTS 
3.1. General Materials 
Various equipments have been used in the animal experiments, 
these are: 
i) a copper vapour laser; 
ii) a laser doppler flowmeter; 
iii) an electro-cautery unit, and 
iv) a stainless steel caliper. 
Also, a few self-designed and home made equipments have also 
been used in the animal experiments, these are: 
i) a thermo-detector; 
ii) a clear acrylic manipulator, and 
iii) a clear acrylic perspex stage. 
In the animal experiments, drugs and chemical have been used for 
pre-medication and anaesthesia of the animals, and these : 
i) Atropine sulphate; 
ii) Pentobarbital sodium, and 
iii) Formaldehyde. 
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3.1.1. Equipment 
3.1.1.1. Copper Vapour Laser 
A prototype Copper Vapour Laser system of Model VCM-20 ( 
Visiray Pty. Ltd., Australia ) ( Figure 3.1 to 3.2 ) with neon as the 
buffer gas, was installed in the Combined Endoscopy Unit, Prince 
of Wales Hospital, Shatin，New Territories, Hong Kong. This 
copper vapour laser, like all other copper vapour lasers, can emit a 
pure green light ( Figure 3.3 ) of wavelength at 510 nm, and a pure 
yellow light ( Figure 3.4 ) of wavelength at 578 nm，or emits both 
green and yellow light together ( Figure 3.5 ). All the laser beams 
are emitted at a standard pulse frequency of 15 kHz and pulse 
duration of 20 ns, which can be classified as a continuous beam 
laser. The difference between this copper vapour laser with the 
other marketed lasers is the power of the Visiray VCM-20 laser 
output can theoretically reach a maximum of 17 Watts with the 
yellow lights at wavelength 578 nm. 
The Visiray VCM-20 copper vapour laser, ( after switching on 
the key at the main switch board ( Figure 3.6 ) and with the tap of 
the running water for the cooling system was turned on ) takes 
about one and a half hour to two hours to warm up to 1600°C, a 
temperature which will vapourize the pure copper inside the laser 
tube. Therefore, time is needed before the copper vapour laser is 
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stabilized for calibration and treatment. Once the laser is stable, 
the laser power can be maintained for about 90 minutes and then 
reduced. The laser beam is transmitted from the laser machine 
through an adapter ( Figure 3.7 ) to the optical fibre which is made 
of quartz with a diameter of 600 |Lim ( Figure 3.8 and 3.9 ). The 
optical fibre can be inserted into the working channel of a 
gastrointestinal endoscope. 
The choice of laser wavelength ( yellow at 578 nm, green at 
510 nm, or green 510 n m + yellow 578 n m )，the calibration and the 
power setting can be selected through a fully electronic facilitated 
Control Panel ( Figure 3.10, 3.11, and 3.12 ). After the power has 
been selected ( Figure 3.13 ), the duration of treatment or exposure 
time of the laser can then be input via the control panel ( Figure 
3.14 and 3.15 ). When all the above steps are done, the machine is 
ready for operation. The emission and continuation of the laser 
beam can be controlled manually by the operator using an on and 
off foot-switch ( Figure 3.16 ). The electronic timer installed inside 
the control panel will count the time of the laser exposure, and the 
display will show the actual time used for the whole treatment 
process ( Figure 3.17 ). At the end of the treatment, the energy (in 
Joules ) used can be calculated by multiplying the power ( in Watts 
)with the time ( in seconds ). 
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3.1.1.2. Laser Doppler Velocimetry 
A laser Doppler flowmeter ( Periflux ), with a 6 m m tip 
optical-fibre, is manufactured by Perimed of Sweden. It is used to 
measure the movement of red blood cells. When red blood cells 
move, the laser light is scattered and a shift in frequency is 
observed. The magnitude of the shift in frequency provides an 
estimate of the rate of blood flow which is expressed in terms of 
Doppler flux. This laser Doppler flowmeter has been used in a trial 
with two rats, but it was then abandoned since the diameter of the 
fibre tip of the laser Doppler probe was found to be inadequate in 
size. 
3.1.1.4. Electro-cautery 
A monopolar electro-cautery set ( Super Frecator，Vamada 
Shadowless Lamp Co., Ltd., Tokyo, Japan ) has been used for 
haemostasis during operations on the animals in the experiments. 
3.1.1.5. Stainless Steel Caliper 
A stainless steel caliper ( Shanghai, China ) was used to 
measure the thickness of the rats' stomach ( Figure 3.18 ) and the 
diameter of the selected mesenteric vein of the rats ( Figure 3.19 ). 
The accuracy of the caliper used is 0.02 m m . 
I P. 45 
I •鬧_•丨丨 
3.1.1.6. Thermo-Detector 
A home made simple thermo-detector ( Figure 3.20 & 3.21 ) 
was used to detect the perforation of the stomach wall in the rats' 
experiments. It has a thermister which can detect a rise in 
temperature, and light up the red L E D light on top of the thermo-
detector. The thermo-detector was designed ( Figure 3.22 ) and 
assembled by Mr. Gary Leung ( M.Phil., Department of Electronic 
Engineering, The Chinese University of Hong Kong ). 
3.1.1.7. Acrylic Manipulator 
A self-designed clear acrylic manipulator ( Figufe 3.23 & 3.24 
) w a s assembled by the Technical Services Unit，The Chinese 
University of Hong Kong. This manipulator has a knob on the top 
that can move the platform up and down. On the side of the 
platform, there is another knob that control the to-and-fro 
movement of the platform. There is a stainless steel ruler mounted 
on one side of the stand as a scale for the height ( Figure 3.25 )• 
3.1.1.8. Perspex Stage 
A home-made perspex stage ( Figure 3.26 ) made of clear 
acrylic was used in the animal experiments with Sprague-Dawley 
rats. A hole of 1.5 cm diameter was made in the center of the stage 
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for the rats' stomach and small bowel to pass through and stabilized 
on it. 
3.1.2. Drugs and chemical 
3.1.2.1. Atropine Sulphate 
Atropine Sulphate injection B.P. ( dl-Hyoscyamine )， 
manufactured by David Bull Laboratories Pty. Ltd., 7-23 Lexia 
Place Mulgrave Victoria 3170 Australia. Ampoules of 0.06 mg/ml, 
1 ml per ampoule were being used in the animal experiments on 
rats as anticholinergic drug. Dosage used was according to the 
"Handbook of Veterinary Drugs, A Compendium for Research and 
Clinical Use" by Irving S. Rossoff; Springer, N e w York ( 1974 ). 
3.1.2.2. Pentobarbital Sodium 
Pentobarbital sodium B.P. was purchased from Sigma 
Chemical Company, U.S.A. ( Cat. #93761，Sigma Chemical 
Company, St. Louis, M O 63178, U.S.A. )• A 5 % solution at pH 10 
was prepared in the Research Laboratory, Department of Surgery, 
The Chinese University of Hong Kong. The dosage used in the rats 
throughout the experiments was 40 mg/kg injected intra-
peritoneally ( I.P. ) and was according to the "Handbook of 
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Veterinary Drugs, A Compendium for Research and Clinical Use" 
by Irving S. Rossoff; Springer, N e w York ( 1974 )• 
3.1.2.3. Formaldehyde 
10% Formaldehyde solution ( formalin ) was prepared in the 
Research Laboratory, Department of Surgery, The Chinese 
University of Hong Kong. Formalin solutions were used to fix the 
rats' stomach for histopathological studies. 
3.1.3. Laboratory Animals 
In the experiments, rats were being used as the animal model. 
All the animals in the experiments were treated with humane methods 
and no cruelty was applied to the animals. 
3.1.3.1. Rats 
Female Sprague-Dawley rats weight from 250 g m to 300 gm 
were obtained from the University Animal House, Faculty of 
Medicine, The Chinese University of Hong Kong. 
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3.1.4. Surgical Instruments 
The instruments used in the animal experiments are as followed: 
# 3 Scalpel x 1 
Thumb Forceps x 2 
Scissors x 1 
Hemostats x 6 
Needle Holder x 1 
3.1.7. Disposable 
#10 Blades 





2/0 Mersilk ( Round bodied 30 m m )，ETfflCON，Ltd., 
Scotland. 
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3.1.9. Histopathological Preparation 
All of the following equipments and accessories required for 
histological studies were provided by the Lee Hysan Clinical 
Research Laboratories, Faculty of Medicine, The Chinese University 
of Hong Kong 
Histokinette 2000 ( Reichert-Jung ) 
Embedding center (Histo-Center II-N，Thermolyne ) 
Microtome ( 1130/Biocut, Reichert-Jung ) 
Glass slides 
Cover glass for slides 
Haematoxylin and Eosin Stain 
Light Microscope 
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3.2. Experiment 1 : Iatrogenic perforation of the rat's stomach by 
the continues application of the Copper 
Vapour Laser at different power level 
3.2.1. Introduction 
Applications of Copper Vapour Laser on superficial vascular 
lesions such as port-wine stain ( Walker et al•，1989; Pickering et al., 
1990; Neumann et al., 1992 ) and cavernous haemangiomas in the 
oral cavity ( Tong et al., 1993 ) have already had satisfactory results. 
Besides these superficial applications of copper vapour laser, there 
were no reports on the application in the gastrointestinal tract on any 
living creatures. Prior to applying the copper vapour laser in humans, 
we havee set up experiments to test the laser's effect and possible 
complication on the gastrointestinal system using animall studies. The 
aim of this experiment is to establish a safe power range for the 
present Copper Vapour Laser system to use in the gastrointestinal 
tract clinically. In the animal model，a fixed power laser beam is 
applied to a fixed spot on the mucosa of the rat's stomach until the 
end point (defined as perforation of the rat's stomach wall) is reached. 
A total of three power levels were being tested. The results obtained 
will help to establish a safety guideline and, if possible, extrapolation 
is made to the clinical applications of the copper vapour laser in the 
human gastrointestinal tract. 
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3.2.2. Methods 
Female Sprague-Dawley rats weighing between 250-300 gm 
were used and were divided into three groups, with five in each 
group. All the rats in the three groups were anaesthetized by intra-
peritoneal injection of 5 % pentobarbital sodium with the dosage of 40 
mg/kg and atropine sulphate was then injected subcutaneously as 
anticholinergics. After the rat was anaesthetized, it was restrained in 
a ventral-dorsal position. A mid-line incision was made from the 
distal edge of the xiphoid cartilage to the umbilicus to explore the 
abdomen. The stomach was located and gently pulled out of the 
abdomen. A perspex stage was then placed over the rat with the rat's 
stomach passing through the perspex stage at the center ( Figure 3.27 
& 3.28 ). The height of the perspex stage was adjusted to avoid any 
compression on the chest wall that may interfere with respiration and 
kill the rat by suffocation. The rat's stomach was then opened 
longitudinally at the greater curvature ( Figure 3.29 ) with a pair of 
scissors. Haemostasis was done by electro-cauterization to avoid 
blood loss. The rat's stomach is divided into two part, the 
forestomach ( nonglandular part ) and the corpus ( glandular part )( 
Figure 3.30 ). The perspex stage was used to stabilized the stomach, 
and six stay-suture were placed at 2，4，6，8，10 and 12 o'clock 
position ( Figure 3.31 & 3.32) in order to stabilize, stretch and flatten 
the stomach. The rat's stomach was stretched to simulate the situation 
during gastrointestinal endoscopy when the stomach is distended with 
air in order to get a better vision for diagnosis and treatment. 
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Prior to the opening of the rat's abdomen, the copper vapour 
laser was calibrated and power was set at the required wattage level. 
After the 
rat's stomach was opened and properly positioned, 
measurement of the thickness of the stomach wall was done using a 
fine caliper ( Figure 3.18 )• The accuracy of the caliper used is 0.02 
m m . The optical fiber was then positioned ( Figure 3.33 ) at 2 m m 
above and perpendicular to the area of mucosa with the aid of a 
micro-manipulator ( Figure 3.23 & 3.24 ). Six spots on the mucosa, 
with two in the forestomach ( nonglandular part ) arid four in the 
corpus ( glandular part ) were selected ( Figure 3.34 ), and treated 
with the copper vapour laser with different pre-set powers until 
perforation of the stomach wall was observed, ( Figure 3.35 & 3.36 ) 
the time taken was recorded. 
In a preliminary study, the thermistor of the home-made thermo-
detector was placed under the rats' stretched stomach in order to 
detect the heat generated by the laser beam at the time when 
perforation of the stomach wall occurred. Theoretically, when the 
laser beam perforate the stomach wall, the thermistor will receive a 
certain amount of heat energy and thus a change in the electrical 
current, and the red L E D light on top of the thermo-detector will 
illuminate immediately. But in this preliminary study, the L E D light 
on the thermo-detector failed to illuminate even sixty seconds after 
the stomach wall was seen perforated. The reason for failure of the 
thermo-detector may be due to the perforation of the stomach wall 
occuring only in the centre of the circular area that receives the laser 
beam, and not the entire area of the thermister. As a result, the laser 
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energy received by the thermistor was considerably less and thus 
illumination of the L E D light of the thermo-detector was delayed. 
After this preliminary study, the use of the thermo-detector was 
abandoned and direct observation for the perforation of the stomach 
with the naked eye was performed. 
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3.2.3. Results 
Using the fine caliper, the thickness of the forestomach was 
measured and averaged to be 0.4 m m whereas the thickness of the 
corpus was 0.6 m m . 
The results of the time taken for the perforation of the rats' stomach 
at three different power settings of the Copper Vapour Laser were 
recorded in Table 3.1, 3.2 and 3.3. 
Table 3.1. Time ( in second ) taken to perforate the 
stretched rat's stomach wall by Copper 
Vapour Laser at 0.5 Watt. 
Forestomach Corpus 
~ # 1 ~ # 2 " H ~ ~ # 4 I # 5 ~ ~ # 6 - ~ 
0.4 m m 0.4 m m 0.6 m m 0.6 m m 0.6 m m 0.6 m m 
6 丨 6 • 13 丨 13 丨 9 I 14 
~ 1 6 ~ 32 ~ 20 22 ： 一 40 
^ 14 — 13 13 20 一 10 
9 1 5 ~ 22 32 29 23 一 
8
 —
 9 5 5
—
 54 31 ~ 48 
11
 —
1 9 18 16 _ 55 16 
11 6 33 22 21 32 
6 7 16 ~ 16 21 I 13 -
Note: The data in the shaded area was omitted due to 
haemorrhage and discontinue of laser treatment. 
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From the Table 3.1, the following Table 3.1a (data unit: seconds 
)were obtained. 
Forestomach Corpus 
Mean 11.38 24.52 
Standard Deviation 6.84 13.43 
Median 9 21 
Range 26 46 
Minimum 6 9 
Maximum 32 55 
Table 3.1a Calculated results from Table 3.1. Showing the 
time ( in second ) taken to perforate the stretched 
rat's stomach wall by Copper Vapour Laser at 0.5 
Watt. 
Table 3.2. Time ( in second ) taken to perforate the 
stretched rat's stomach wall by Copper 
Vapour Laser at 1.0 Watt. 
Forestomach Corpus 
~ # 1 I # 2 # 3 ~ ~ # 4 ~ I # 5 ~ ~ F 6 ~ 
0.4 m m 0.4 m m 0.6 m m 0.6 m m 0.6 m m 0.6 m m 
r 12 I 44 I 20 I 11 I 16 " 
7 17 一 63 67 79 59 
丨 7 6 ~ 18 9 ~ 10 _ 14 
5 ~ 6 6 ~ 9 ~ 8 " 12 
12 ~ 1 2 ~ 24 — 47 — 
7 7 19 26 1 2 ~ 10 _ 
~ 6 ~ 7 I 15 I 18 I 24 I 13 
Note: The data in the shaded area was omitted due to 
haemorrhage and discontinue of laser treatment. 
I P. 56 
II I 
From the Table 3.2, the following Table 3.2a ( data unit: seconds 
)were obtained. 
Forestomach Corpus 
Mean ^29 25.12 
Standard Deviation 3.54 20.86 
Median 7 17 
Range 12 73 
Minimum 5 6 
Maximum 17 79 
Table 3.2a Calculated results from Table 3.2. Showing the 
time ( in second ) taken to perforate the stretched 
rat's stomach wall by Copper Vapour Laser at 1.0 
Watt. 
Table 3.3. Time ( in second ) taken to perforate the 
stretched rat's stomach wall by Copper 
Vapour Laser at 2.0 Watt. 
Forestomach Corpus 
~ # 1 I ~ # 2 # 3 ~ ~ W l ~ I # 5 ~ ~ # 6 ~ 
0.4 m m 0.4 m m 0.6 m m 0.6 m m 0.6 m m 0.6 m m 
9" I 5 I 17 I 7 I 5 I 27 ~ 
5 ~ 10 5
 —
4 5 ~ 5 
6 4 8 8 8 1 1— 
18 ~ 9 ~ 51 17 77 ~ 
5 ~ 5 ~ 7 7 10 6 
6 ~ 24 8 — 1 3 — 
~ 6 18 36 34 28 “ 30 
: ::: 7 15 12 1 4 6 0 -
I I ^ 3 I 8 1 5 1 8 I 9 
Note: The data in the shaded area was omitted due to 
haemorrhage and discontinue of laser treatment. 
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From the Table 3.3, the following Table 3.3a ( data unit: seconds 
)were obtained: 
Forestomach Corpus 
Mean ^82 17.12 
Standard Deviation 5.83 17.36 
Median 6 9 
Range 21 73 
Minimum 3 4 
Maximum 24 77 
Table 3.3a Calculated results from Table 3.3. Showing the 
time ( in second ) taken to perforate the stretched 
rat's stomach wall by Copper Vapour Laser at 2.0 
Watt. 
Histopathological examination of the stomach specimens 
revealed that there were carbonization debris ( Figure 3.37 & 3.38 ) at 
the site of perforation following treatment with the copper vapour 
laser. Necrosis of the tissue next to the perforation site was seen. 
This may be a reaction to the heat generated by the red blood cells 
after absorption of the laser energy. 
The Mann-Whitney U - Wilcoxon Rank Sum W Test was used to 
analyse the statistical difference between the time used ( mean 士 S.D. 
)to perforate the forestomach and the corpus by the Copper Vapour 
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Laser in the different power groups. There was significant difference 
and the results are shown as followed : 
Power Level Forestomach Corpus p value 
0.5 Watt 11.38 士 6.84 24.52 土 13.43 <0.05 
1.0 Watt 8.29 ±3.54 25.16 士 20.86 <0.05 
2.0 Watt 8.82 ±5.83 17.12 ±17.36 <0.05 
The Multiple Comparisons Kruskal-Wallis Test was used to 
analyse the difference between the time taken by the different power 
setting for the laser to perforate the rats' forestomach and the corpus. 
There were significant difference in the forestomach but no 
significant difference in the corpus. The results are as followed: 
Forestomach Corpus 
0.5 Watt I 11.38 ±6.84 I I 24.52 ±13.43 I 
1.0 Watt 8.29 士 3.54 25.16 土 20.86 
2.0 Watt 8.82 ±5.83 17.12 ±17.36 
p value <0.05 | N S | ； 
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3.2.4. Discussion 
In this experiment the shortest and longest time require to 
perforate the full thickness of the rats' stomach ( the forestomach and 
the corpus ) by continuous exposure to the copper vapour laser were 3 
seconds at 2.0 Watt and 79 seconds at 1.0 Watt respectively. Since 
the difference between the two time interval was so great, it appeared 
that the copper vapour laser can be potentially dangerous when used 
in a continuous exposure setting in the gastrointestinal tract of the 
rats. Although the thickness of the human gastrointestinal tract and 
the overlying epithelium of varix may vary in different site, and 
between patients, the thickness of the rats' stomach is much less than 
that of the human. Therefore the extrapolation of the results obtained 
from the rats may not be possible. However, the potential danger of 
continuous exposure to the copper vapour laser at high power level 
can not be underestimated. 
In the experiment, the copper vapour laser was focused at a fixed 
spot, whereas in the human setting, e.g. the application in 
dermatology for the treatment of port-wine stains, the laser is being 
moved and used in a paint brush fashion with better dissipation of the 
heat energy. 
As indicated in the data for the three power levels, exposure of 
copper vapour laser in the gastrointestinal tract under a high power 
setting with continuous exposure can result in perforation. W e 
speculate that a power setting at 1 Watt and a pulse duration of 2 
seconds for each laser exposure in the human gastrointestinal tract 
may be safe. 
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3.3. Experiment 2 : Obliteration of the rats, mesenteric vein with 
the Copper Vapour Laser 
3.3.1. Introduction 
The applications of the Copper Vapour Laser with the 578 n m 
yellow light in the treatment of various superficial vascular lesions 
gives satisfactory results ( Tong et al” 1993; Walker et al., 1989; 
Pickering et al., 1990; Neumann et al., 1992). The reported result on 
the comparison of the 577 n m dye laser and the 578 n m copper 
vapour laser showed that the copper vapour laser is more effective in 
treating large vessel disease ( Waner et al., 1992 ). A hypothesis was 
made that larger vessels can be obliterated if the laser power of the 
copper vapour laser at 578 n m is increased. To assess the 
applicability of the Copper Vapour Laser an option for laser treatment 
of the oesophageal varices, an animal model was set up to measure 
the effect of the Copper Vapour Laser in the treatment of rats' 
mesenteric veins. The aim is to apply the copper vapour laser on the 
rats' mesenteric vein with a fixed power in order to determine the 
optimal treatment dose for the obliteration of the blood vessel. If an 
optimal treatment dose is established, extrapolation of the result to the 
treatment of oesophageal varices in human with the high powered 
copper vapour laser can be made. 
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3.3.2. Method 
The rats used in Experiment I were also used for this part of the 
study. Exposure of the stomach to laser treatment and perforation of 
the stomach did not affect the general condition of the animal. The 
caudal ( inferior ) mesenteric vein was located and then pulled out 
from the abdomen. With the perspex stage positioned over the rat's 
trunk, the mesenteric vein along with the bowel was passed through 
the hole at the middle of the perspex stage, and stablized on the 
perspex stage ( Figure 3.39 )• The diameter of the caudal mesenteric 
vein was measured with a caliper ( Figure 3.19 )，and a section of 
mesenteric vein with a diameter of 1 m m was selected for the 
treatment with laser. After the colour ( yellow, wavelength 578 n m ) 
selection, calibration and power ( at 0.5 Watt ) setting, of the copper 
vapour laser were set, the optical fibre of the copper vapour laser was 
positioned perpendicular ( Figure 3.40 )to the vein with the aid of the 
manipulator. The distance between the vein and the fibre tip was kept 
at 2 m m . Continues exposure of copper vapour laser was then applied 
to the mesenteric vein ( Figure 3.41 ) aiming at obliteration of the 
vein. The time taken for any changes to occur was recorded with a 
stop-watch. 
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3.3.3, Results 
All the ten rats' caudal mesenteric vein perforated before 
obliteration occurred, and massive haemorrhage occured ( Figure 3.42 
& 3.43 ) as a result of laser treatment. Haemostasis of the bleeding 
with the continuous treatment with the copper vapour laser was 
attempted, but coagulation occurred only on the surface of the blood 
and definitive haemostasis failed. The data and the calculated data ( 
in seconds ) were listed in Table 3.4 and Table 3.4 respectively. 
Rat no. •
 T i m e 











Table 3 .4 Time ( in second ) used for the perforation of 
the rats' (n=10 ) caudal mesenteric vein with 
continuous exposure of Copper Vapour 
Laser power at 0.5 Watt. 
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Time 
(in seconds ) 
Mean 3.3 





Table 3.5 Calculated data for the time ( in second ) used 
for the perforation of the rats' ( n=10 ) caudal 
mesenteric vein with continuous exposure of 
Copper Vapour Laser at 0.5 Watt. 
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3.3.4. Discussion 
All the selected mesenteric veins of the ten rats were perforated 
by continuous exposure of the copper vapour laser at 0.5 Watt of 
power before any vessel obliteration was observed, this is 
complicated by massive haemorrhage. This raise a potential concern 
in the endoscopic treatment of oesophageal varices. The continuous 
exposure of the Copper Vapour Laser with a power setting at 0.5 
Watt can perforate the rats' mesenteric vein wall, it may also 
perforate the oesophageal varices. Furthermore, the blood in the 
oesophageal varices is under high pressure ( = 12 m m H g ) because 
of underlying portal hypertension ( Sabiston, 1986 ), and such 
perforation may exacerbate the bleeding episode. 
In injection sclerotherapy, bleeding from the needle puncture 
site may sometime lead to uncontrollable haemorrhage. Such 
bleeding may sometimes be controlled by tamponade with the shaft 
of the endoscope but often requires other techniques like insertion of 
a Sengstaken tube. The recently introduced rubber band ligation 
avoids this problem but if the band slips off, rupture of the varix and 
massive haemorrhage may occur. Laser therapy theoretically is ideal 
for the treatment of oesophageal varices, because laser works by 
changing light energy into heat energy, without any direct contact 
with the varix. But if the varix wall is vapourized before the varix is 
obliterated, rupture of the varix may lead to uncontrolled 
haemorrhage, as observed in our experiment. 
Whether the vein wall ruptures first or obliteration occurs first 
is dependent on the differential heating of the tissue. Rapidly 
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flowing blood in the caudal mesenteric vein may carry the heat away 
(heat sink effect )，whereas vein wall that is stationary, may absorb 
a comparatively greater amount of heat energy from the Copper 
Vapour Laser, and become vapourized and perforated. 
One possible limitation of the experiment is that the wall 
thickness of the rat's caudal mesenteric vein may be thinner than that 
of the human oesophageal varices. However in patients where the 
oesophageal varices show a cherry red spot, the wall may be very 
thin and is at risk of perforation with laser therapy. 
Although haemostasis of the caudal mesenteric vein can be done 
by direct compression on the bleeding site, no attempt was made 
because the aim of this experiment is to establish a safe and an 
optimal dose for the potential treatment of human oesophageal varices 
with endoscopy. Direct compression of the bleeding varices without 
the aid of other instrument is also not practical in this setting. 
From our data, the hypothesis that increasing power of the 
copper vapour laser can obliterate larger vessel can not be 
substantiated. 
I P. 66 
CHAPTER 4 ； CONCT JTSTON 
Applications of Copper Vapour Laser on superficial vascular 
lesions such as port-wine stain ( Walker et al., 1989; Pickering et al., 
1990; Neumann et al” 1992 ) and cavernous haemangiomas in the oral 
cavity ( Tong et al” 1993 ) have achieved remarkable results. Such 
superficial vascular lesions involved large numbers of capillaries which 
can only be seen under microscopy, and the copper vapour laser can 
obliterate these capillaries even with a low power setting. 
After the experiment ( Experiment II ) using the copper vapour 
laser to obliterate the rat's caudal mesenteric vein, we concluded that 
increasing the power of the copper vapour laser cannot obliterate larger 
vessel in a safe manner. Perforation of the rats' mesenteric vein occurs 
before obliteration also makes the copper vapour laser potentially 
dangerous in the treatment of vascular lesions consisting of larger 
vessels. The data from Experiment I which aim at the establishment of a 
safe dose for the copper vapour laser treatment in the human 
gastrointestinal tract showed that there is an unpredictable risk of laser 
perforation of the rats' stomach wall especially at a higher power setting. 
In conclusion, although extrapolation of animal data to humans should 
be done with caution, our data cannot confirm the safety of the use of 
high power copper vapour laser in the humans. The risk of vapourising 
the wall of the varix before obliteration makes clinical trial of this laser 
in patients with bleeding oesophageal varices hazardous. 
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Figure 3.1 Copper Vapour Laser System ( VCM-20 Visiray Pty. Ltd., 
Australia). 
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Figure 3.2 Another view of the Copper Vapour Laser System ( V C M -
: 20 Visiray Pty. Ltd., Australia )• 
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Figure 3.3 Laser beam in green colour ( 510 n m ) emitted from the 
Copper Vapour Laser. 
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Figure 3.4 Laser beam in yellow colour ( 578 n m ) emitted from the 
Copper Vapour Laser. 
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Figure 3.5 Laser beam in green ( 510 n m ) + yellow ( 578 n m ) colour 
emitted from the Copper Vapour Laser. 
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Figure 3.6 The main switch board at the front of the Copper Vapour 
Laser 
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Figure 3.7 The adapter at one end of the quartz fibre. Connected to 
the Copper Vapour Laser. 
Figure 3.8 The treatment end of the quartz fibre. 
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Figure 3.9 The treatment end of the quartz fibre fixed at the acrylic 
manipulator. 
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Figure 3.10 The control panel of the Copper Vapour Laser. Standby to 
use. 
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Figure 3.11 The control panel of the Copper Vapour Laser. Selection 
of colour. 
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Figure 3.12 The control panel of the Copper Vapour Laser. Ready for 
calibration. 
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Figure 3.13 The control panel of the Copper Vapour Laser. 
Calibration and selection of power. 
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Figure 3.14 The control panel of the Copper Vapour Laser. Input 
selection of the time (in seconds )of exposure. 
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Figure 3.15 The control panel of the Copper Vapour Laser. After 
inputting of the time (in seconds ) of exposure. 
Figure 3.16 The foot-switch for the control of the shutters or the 
emission of the Copper Vapour Laser. 
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Figure 3.17 The control panel of the Copper Vapour Laser. The 
display showed the real time ( in second ) used for the 
treatment. 
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Figure 3.18 Measuring the thickness of the rat's stomach with the 
stainless steel caliper. 
I P. 76 
B y j y . •‘ 、， 
Figure 3.19 Measuring the diameter of the mesenteric vein of the rat 
with the stainless steel caliper. 
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Figure 3.20 The home made Thermo-detector. 
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Figure 3.21 A close-up view of the Thermo-detector. 




































































































































































































































Figure 3.23 The self-designed clear acrylic manipulator. 
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Figure 3.24 An other view of the clear acrylic manipulator. 
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Figure 3.25 A close-up front view of the clear acrylic manipulator. 
Note the stainless steel ruler mounted on the side of the 
manipulator. 
Figure 3.26 The home-made clear acrylic perspex stage. 
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Figure 3.27 The pulled out stomach passed through and placed on the 
perspex stage. 
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Figure 3.28 A close-up view of the pulled out stomach of the rat in 
Figure 3.27. 
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Figure 3.29 The rat's stomach opened longitudinally at the greater 
curvature. Note the food stuff in the stomach. 
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Figure 3.30 The opened rat's stomach after removal of the food stuff. 
The whitish and smaller portion on the right is the non-
glandular part or the forestomach of the rat. The darker 
and the larger portion on the left is the glandular part or 
the corpus of the rat. 
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Figure 3.31 Six stay sutures was placed at 2, 4，6, 8，10 and 12 o'clock 
position of the rat's stomach. 
Figure 3.32 A close-up view of the rat's stomach at Figure 3.33. 
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Figure 3.33 The optical quartz fibre was placed in position at 2 m m 
from the target ( rat's stomach )with the aid of the acrylic 
manipulator. 
Sites for Laser Exposure in Rats' Stomach 
Stay Suture #3 
(2/0 Mersiik) 
Figure 3.34 The six sites selected at the mucosa of the rat's stomach. 
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Figure 3.35 The six perforation made by the continuous emission of 
the Copper Vapour Laser at the rat's stomach. 
r '^^BH ‘ 
Figure 3.36 A close-up view of Figure 3.35. 
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Figure 3.37 Histopathology of the site where the laser was targeted. 
Necrosis and carbonization debris were found at the target 
site. 
Figure 3.38 Histopathology of the site of perforation. Necrosis and 
carbonization debris were found at the edge of perforation. 
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Figure 3.39 The rat's bowel was placed over the clear perspex stage. 
Figure 3.40 The quartz fibre was positioned perpendicular to the 
mesenteric vein. 
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3.2.3. Results 
Measurement made by the fine caliper, the thickness of the 
forestomach found to be 0.4 m m whereas the thickness of the corpus 
found to be 0.6 m m . 
The results of the time taken for the perforation of the rats' stomach 
at three different power settings of the Copper Vapour Laser were 
recorded in Table 3.1, 3.2 and 3.3. 
Table 3.1. Time ( in second ) taken to perforate the 
stretched rat's stomach wall by Copper 
Vapour Laser at 0.5 Watt. 
Forestomach Corpus 
# 1 # 2 ~ # 3 ~ # 4 # 5 " " ” # 6 
0.4 m m 0.4 m m 0.6 m m 0.6 m m 0.6 m m 0.6 m m 
6 6 13 13 9 J 14 
16 32 20 . 22 40 
7 14 13 13 _ 20 10 
9 15 22 32 29 23 . 
8 9 55 54 一 31 48 
_ J J _ ~ l 9 ~ 18 ‘ 16 一 5 5 16 一 
11 6 33 22 21 32 
6 I 7 I 16 I 16 I 21 I 13 
Note: The data in the shaded area was omitted due to 
haemorrhage and discontinue of laser. 
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Figure 3.41 Continuous exposure of the Copper Vapour Laser to the 
mesenteric vein. 
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Figure 3.42 Haemorrhage occur at the site of laser exposure on the 
mesenteric vein. 
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From the Table 3.1, the following Table 3.1a ( data unit: seconds 
)were obtained. 
Forestomach Corpus 
Mean 11.38 24.52 
Standard Deviation ^84 13.43 
Median 9 21 
Range 26 46 . 
Minimum 6 9 
Maximum 32 55 
Table 3.1a Calculated results from Table 3.1. Showing the 
time (in second ) taken to perforate the stretched 
rat's stomach wall by Copper Vapour Laser at 0.5 
Watt. 
Table 3.2. Time ( in second ) taken to perforate the 
stretched rat's stomach wall by Copper 
Vapour Laser at 1.0 Watt. 
Forestomach Corpus 
~ # 1 ~ ~ # 2 # 3 ~ # 4 I # 5 ~ ~ # 6 ~ 
0.4 m m 0.4 m m 0.6 m m 0.6 m m 0.6 m m 0.6 m m 
5 12 I 44 I 20 I 11 I 16 
7 17 63 67 一 7 9 59 一 
Z 9 10 14 
5 6 6 ~ 9 8 12""“ 
12 19 一 Ta 7； 
i± L± 24 £7 ^ 
7
 7 19 26 ~ " 1 2 ~ 10 -
6 I 7 I 15 I 18 I 24 I 13 
Note: The data in the shaded area was omitted due to 
haemorrhage and discontinue of laser. 
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Figure 3.43 Massive haemorrhage at the mesenteric vein after 
continues exposure by the Copper Vapour Laser. 
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